Physician profile
Mark H Widick
NPI 1871557629
$2,140.89
in general payments reported to CMS, 2019-2025
11 companies · $53.70 in 2025
The $53.70 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,261 · 2020: $24.14 · 2021: $29.11 · 2022: $332 · 2023: $202 · 2024: $239 · 2025: $53.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $815.40 | 2019-2022 | |
| Med-El Corporation | $488.87 | 2019-2024 | Mi1250 Synchrony 2 Flexsoft |
| Acclarent, INC | $243.96 | 2019-2023 | Acclarent Navwire, Acclarent Aera |
| Advanced Bionics, LLC | $189.64 | 2020-2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Stryker Corporation | $175.07 | 2019-2022 | |
| Cochlear Americas | $88.29 | 2023 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Pfizer INC. | $51.59 | 2023 | |
| Smith+Nephew, INC. | $39.17 | 2022-2025 | Tula |
| Integra Lifesciences Corporation | $18.68 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Mimedx Group, INC. | $15.14 | 2025 | |
| Medtronic, INC. | $15.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Widick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.